Literature DB >> 33717374

Hyperhomocysteinemia as the only risk factor in a young man presenting with ST-elevation myocardial infarction.

Charalampos Varlamos1, Christos Pappas1, Estela Kiouri1, Nikolaos Kosmas1, Despoina-Rafailia Benetou1, Loukianos S Rallidis1.   

Abstract

Hyperhomocysteinemia has been established as a risk factor for cardiovascular events. This case of a 23-year-old male, presenting with acute coronary thrombosis and unremarkable past medical history, highlights the importance of measuring homocysteine levels in young individuals with acute coronary syndromes, especially those without conventional risk factors. <Learning objective: Hyperhomocysteinemia could be rarely the only risk factor causing an acute coronary syndrome, especially in very young individuals; Optical coherence tomography could provide valuable information regarding the cause of occlusion in an unexpected clinical presentation; Gene testing for thrombophilia should be considered for very young individuals with acute coronary syndrome without conventional risk factors; Randomized controlled trials have failed to prove a clinical benefit in patients treated with folic acid.>.
© 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary thrombus; Homocysteine; Hyperhomocysteinemia; Inherited metabolic disorders; Premature myocardial infarction; Preventive medicine

Year:  2020        PMID: 33717374      PMCID: PMC7917407          DOI: 10.1016/j.jccase.2020.10.004

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.

Authors:  Linda L Humphrey; Rongwei Fu; Kevin Rogers; Michele Freeman; Mark Helfand
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

Review 2.  Homocysteine and thrombosis: from basic science to clinical evidence.

Authors:  Anetta Undas; Jan Brozek; Andrzej Szczeklik
Journal:  Thromb Haemost       Date:  2005-11       Impact factor: 5.249

3.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Authors:  Jane M Armitage; Louise Bowman; Robert J Clarke; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Peter Sleight; Richard Peto; Rory Collins
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

Review 4.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

5.  Atherothrombosis in 2 vascular territories in a young woman: importance of thrombophilia testing.

Authors:  Ruxandra Jurcut; Anca Florian; Dan Deleanu; Ileana Arsenescu; Ciprian Jurcut; Daniel Coriu; Carmen Ginghina
Journal:  Clin Appl Thromb Hemost       Date:  2010-05-11       Impact factor: 2.389

6.  Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)

Authors:  P Goyette; A Pai; R Milos; P Frosst; P Tran; Z Chen; M Chan; R Rozen
Journal:  Mamm Genome       Date:  1998-08       Impact factor: 2.957

7.  Hyperhomocysteinemia in a young woman presenting with acute myocardial infarction: Case report.

Authors:  Seher Gokay; Davran Ciçek; Haldun Müderrisoğlu
Journal:  Interv Med Appl Sci       Date:  2013-03-19

8.  EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaque Erosion): A 1-Year Follow-Up Report.

Authors:  Lei Xing; Erika Yamamoto; Tomoyo Sugiyama; Haibo Jia; Lijia Ma; Sining Hu; Chao Wang; Yingchun Zhu; Lulu Li; Maoen Xu; Huimin Liu; Krzysztof Bryniarski; Jingbo Hou; Shaosong Zhang; Hang Lee; Bo Yu; Ik-Kyung Jang
Journal:  Circ Cardiovasc Interv       Date:  2017-12       Impact factor: 6.546

9.  Role of methylenetetrahydrofolate reductase 677C->T polymorphism in the development of premature myocardial infarction.

Authors:  Loukianos S Rallidis; Argiro Gialeraki; Christoforos Komporozos; Panagiotis Vavoulis; Georgios Pavlakis; Anthi Travlou; Ioannis Lekakis; Dimitrios T Kremastinos
Journal:  Atherosclerosis       Date:  2008-02-05       Impact factor: 5.162

10.  Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).

Authors:  Haibo Jia; Jiannan Dai; Jingbo Hou; Lei Xing; Lijia Ma; Huimin Liu; Maoen Xu; Yuan Yao; Sining Hu; Erika Yamamoto; Hang Lee; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.